[go: up one dir, main page]

GB202417404D0 - Antisense oligonucleotides for the treatment of kidney disorders - Google Patents

Antisense oligonucleotides for the treatment of kidney disorders

Info

Publication number
GB202417404D0
GB202417404D0 GBGB2417404.7A GB202417404A GB202417404D0 GB 202417404 D0 GB202417404 D0 GB 202417404D0 GB 202417404 A GB202417404 A GB 202417404A GB 202417404 D0 GB202417404 D0 GB 202417404D0
Authority
GB
United Kingdom
Prior art keywords
treatment
antisense oligonucleotides
kidney disorders
kidney
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2417404.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB2417404.7A priority Critical patent/GB202417404D0/en
Publication of GB202417404D0 publication Critical patent/GB202417404D0/en
Ceased legal-status Critical Current

Links

GBGB2417404.7A 2024-11-27 2024-11-27 Antisense oligonucleotides for the treatment of kidney disorders Ceased GB202417404D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2417404.7A GB202417404D0 (en) 2024-11-27 2024-11-27 Antisense oligonucleotides for the treatment of kidney disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2417404.7A GB202417404D0 (en) 2024-11-27 2024-11-27 Antisense oligonucleotides for the treatment of kidney disorders

Publications (1)

Publication Number Publication Date
GB202417404D0 true GB202417404D0 (en) 2025-01-08

Family

ID=94084501

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2417404.7A Ceased GB202417404D0 (en) 2024-11-27 2024-11-27 Antisense oligonucleotides for the treatment of kidney disorders

Country Status (1)

Country Link
GB (1) GB202417404D0 (en)

Similar Documents

Publication Publication Date Title
IL307787A (en) Antisense oligonucleotides and their use for treatment of neurodegenerative disorders
GB202417404D0 (en) Antisense oligonucleotides for the treatment of kidney disorders
EP4096680A4 (en) ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
AU2023390632A1 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202400404D0 (en) Antisense oligonucleotides for the treatment of polg-related disorders
GB202508058D0 (en) Antisense oligonucleotides for the treatment of renal disorders
GB202502057D0 (en) Antisense oligonucleotides for the treatment of renal disorders
AU2024246572A1 (en) Antisense oligonucleotides for the treatment of liver disease
GB202417415D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
GB202410747D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
GB202408796D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
CA3286002A1 (en) Antisense oligonucleotides for the treatment of neurological disorders
GB202313645D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
GB202418430D0 (en) Antisense oligonucleotides for the treatment of migrane
GB202416174D0 (en) Antisense oligonucleotides for the treatment of migraine
GB202502170D0 (en) Antisense oligonucleotides for the treatment of disease
GB202502460D0 (en) Antisense oligonucleotides for the treatment of cancer
GB202306060D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202217580D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202410840D0 (en) Antisense oligonucleotides for the treatment of endocrine system disorders
IL319679A (en) Antisense oligonucleotides for the treatment of canavan disease
GB202502333D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202414347D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202410081D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
HK40085170A (en) Antisense oligonucleotides for treatment of neurological disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)